SV 572 25 (Tivicay 25 mg)
Generic Name: dolutegravir
Pill with imprint SV 572 25 is Yellow, Round and has been identified as Tivicay 25 mg. It is supplied by ViiV Healthcare.
Tivicay is used in the treatment of hiv infection and belongs to the drug class integrase strand transfer inhibitor. There is no proven risk in humans during pregnancy. Tivicay 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SV 572 25
Tivicay
- Generic Name
- dolutegravir
- Imprint
- SV 572 25
- Strength
- 25 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Integrase strand transfer inhibitor
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ViiV Healthcare
- National Drug Code (NDC)
- 49702-0227
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
sodium starch glycolate type A corn,
sodium stearyl fumarate,
ferric oxide yellow,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Related Images for "SV 572 25"
More about Tivicay (dolutegravir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 19 Reviews
- Drug class: integrase strand transfer inhibitor
- FDA Alerts (1)
- FDA Approval History
Consumer resources
- Patient Information
- Tivicay (Advanced Reading)
- Tivicay (Dolutegravir 10 mg)
- Tivicay (Dolutegravir 25 mg and 50 mg)
- Other brands
- Tivicay PD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.